On Oct 6-8 we will be attending both CPHI in Milan and CRN Annual Signature Event in Carlsbad, California. Hope to meet you there!
Meet us at ISAPP 2026 in Tokyo Oct 6-8 and don't miss our poster session.
We offer patented, safe, scientifically documented solutions that are supported by robust, state-of-the-art preclinical and clinical studies. Using validated research methodologies, we can help you develop evidence-based health solutions and proven probiotics.
To date, our scientists and research groups around the globe have published more than 320 peer-reviewed scientific articles and more than 80 clinical trials for the strain LP299V® alone. We also hold more than 350 granted patents and patent applications.
Probi scientists, as well as other research groups, have conducted multiple human clinical trials in the fields of digestive health, iron absorption, immune health, and bone health, among others. A sampling of these studies can be accessed via our digital library.
We tirelessly pursue new insights and knowledge, using them to help you create specialized health solutions that offer unique benefits. Our expertise fuels our process, from research to manufacturing, enabling us to shorten our time to market without compromising quality.
At Probi® we know that there is always more to learn—about strains we’ve been using for years, as well as undiscovered strains. That’s why we collaborate closely with international partners and academic groups, conducting state-of-the-art preclinical and clinical trials, investigating the underlying mechanisms, and evaluating the health effects of our probiotics.
